<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-01T10:01:51+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>欧康维视OT-401启动真实世界研究，这款首创新药有望加速上市</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/75p9j49yx7FAy-3teG6RiA</id>
    <link href="https://mp.weixin.qq.com/s/75p9j49yx7FAy-3teG6RiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肝癌大药：索拉非尼国内多家获批，未来或竞争激烈</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/SUoz8PCXquDqWdF2iSgpOQ</id>
    <link href="https://mp.weixin.qq.com/s/SUoz8PCXquDqWdF2iSgpOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】德琪医药：附属德琪浙江收到一笔2678.1万元的政府奖励...</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/EUx3ufuu9BcpXN0XNmk-1Q</id>
    <link href="https://mp.weixin.qq.com/s/EUx3ufuu9BcpXN0XNmk-1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛医药获得基于PROTAC技术的MDM2蛋白降解剂的独家许可</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/cYloKFyFP5C2PMKHoVqSjw</id>
    <link href="https://mp.weixin.qq.com/s/cYloKFyFP5C2PMKHoVqSjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药人的圣诞盛宴！行业大咖与您共聚石家庄免费制剂技术会议</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/978q0pCJteZB6qZdAm3C2A</id>
    <link href="https://mp.weixin.qq.com/s/978q0pCJteZB6qZdAm3C2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为什么这款改良新药可以获批？有什么看点？</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/qGc86G5DhvGv6EgbjiBZOg</id>
    <link href="https://mp.weixin.qq.com/s/qGc86G5DhvGv6EgbjiBZOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>溶瘤病毒治疗挑战与进展</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/QYYp0WOyQRkTjtC1lQ3Axg</id>
    <link href="https://mp.weixin.qq.com/s/QYYp0WOyQRkTjtC1lQ3Axg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药子公司—成都盛迪医药获得药品注册批件</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/Kq9ufvA452biNvKUyT-x7w</id>
    <link href="https://mp.weixin.qq.com/s/Kq9ufvA452biNvKUyT-x7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石药集团业绩持续上涨；在研新药管线丰富</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/_xtIa8ysgbvTFILzmFqcOw</id>
    <link href="https://mp.weixin.qq.com/s/_xtIa8ysgbvTFILzmFqcOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一文概览，国际中等特色专科药企业：丽珠集团</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/Yz9jZatGR9iJlVQdeN0pxg</id>
    <link href="https://mp.weixin.qq.com/s/Yz9jZatGR9iJlVQdeN0pxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】艾伯维(ABBV.US)宣布Humira用于治疗新适应症获批...</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/jAbiNxd1b3z388LyyYEExA</id>
    <link href="https://mp.weixin.qq.com/s/jAbiNxd1b3z388LyyYEExA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晖致正式成立，致力于满足全球不断变化的医疗需求</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/m_TB0V0UqyD7CbQ5v_M6rA</id>
    <link href="https://mp.weixin.qq.com/s/m_TB0V0UqyD7CbQ5v_M6rA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>胰岛素类产品药学研究基本技术要求的考虑</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/yhT36gZuGyVAAG2X14EKkg</id>
    <link href="https://mp.weixin.qq.com/s/yhT36gZuGyVAAG2X14EKkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有人@你，石家庄免费制剂技术会议来了</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/sqL32vDX2JGNdhcvoWO-sg</id>
    <link href="https://mp.weixin.qq.com/s/sqL32vDX2JGNdhcvoWO-sg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百奥泰向EMA递交贝伐珠单抗注射液上市许可申请</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/DCJOxcC5SCPPz26xpnOxpA</id>
    <link href="https://mp.weixin.qq.com/s/DCJOxcC5SCPPz26xpnOxpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1/PDL1联合疗法：癌症免疫治疗的新纪元</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/eFPFrPDTVWz4gObKwOrgzA</id>
    <link href="https://mp.weixin.qq.com/s/eFPFrPDTVWz4gObKwOrgzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>分享：年销售250亿美金的沙坦类药物前景如何？</title>
    <updated>2020-11-28T18:18:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/4V3fDF-ZtRb_2HbzptSs-Q</id>
    <link href="https://mp.weixin.qq.com/s/4V3fDF-ZtRb_2HbzptSs-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>豪森药业创新药项目荣获第六届中国工业大奖表彰奖</title>
    <updated>2020-11-28T18:18:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/HBH6NCJbu9BaCMoUNqncHA</id>
    <link href="https://mp.weixin.qq.com/s/HBH6NCJbu9BaCMoUNqncHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯37|纵览全球药物靶点动态</title>
    <updated>2020-11-28T18:18:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/ZwfeWNNp8fvUCiFhNwuuKg</id>
    <link href="https://mp.weixin.qq.com/s/ZwfeWNNp8fvUCiFhNwuuKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】Arcturus与新加坡联合开发的疫苗ARCT-021进展良好...</title>
    <updated>2020-11-28T18:18:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/xF1zrLG9DevCP3Y6hjDYEA</id>
    <link href="https://mp.weixin.qq.com/s/xF1zrLG9DevCP3Y6hjDYEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>